Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 26.96
-0.15 (-0.55%)
At close: Sep 23, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.39 billion as of September 23, 2026. Its market cap has decreased by -21.24% in one year.
Market Cap
2.39B
Enterprise Value
1.24B
Revenue
394.29M
Ranking
n/a
PE Ratio
361.83
Stock Price
26.96
ChartMarket Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.39B, a decrease of -60.83%. That is a compound annual growth rate of -18.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 2.39B | -18.05% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 2.76B |
| Yantai Zhenghai Biotechnology | 2.76B |
| Hubei Goto Biopharm Group | 2.74B |
| Shenzhen Bioeasy Biotechnology | 2.71B |
| Shanghai Universal Biotech | 2.64B |
| Shandong Sito Bio-technology | 2.48B |
| Jilin Jian Yisheng Pharmaceutical | 2.37B |
| Jiangsu CoWin Biotech | 2.34B |